Population
Human liver specimens of chronic non-A, non-B hepatitis patients who were seropositive for antibodies to HCV
Design
Other
Authors
Loading...
Enables tissue-level HCV detection in seropositive patients; leaves open standardization and clinical adoption of in situ hybridization.
Demonstrates the ability to localize HCV RNA in the cytoplasm of hepatocytes using non-radioactive in situ hybridization in patients with chronic NANB hepatitis.
Yamada et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: